Weikaier Pharmaceutical Technology is based in Suzhou, China. It has raised $63M in total funding. Latest round: Series C.
Weikaier Pharmaceutical Technology is based in Suzhou, China. Weikaier Pharmaceutical Technology has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Weikaier Pharmaceutical Technology runs through 2024; nothing later has been disclosed. Investors on record include Ruixing Investment Management.
Weikaier Pharmaceutical Technology totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide